Method of producing a cationic liposomal preparation...

Details Method of producing a cationic liposomal preparation... Method of producing a cationic liposomal preparation...

2010-08-18

2011-12-13

Long, Scott (Department: 1633)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C514S449000

Reexamination Certificate

active

08075913

ABSTRACT:
A method for producing a cationic liposomal preparation comprising a lipophilic active compound with physical and chemical stability during manufacturing, storing and reconstituting, and further a cationic liposomal preparation obtainable by this method as well as specific cationic liposomal preparations as well as pharmaceutical compositions are disclosed.

REFERENCES:
patent: 5415869 (1995-05-01), Straubinger et al.
patent: 5424073 (1995-06-01), Rahman
patent: 5549910 (1996-08-01), Szoka
patent: 5578320 (1996-11-01), Janoff
patent: 5648090 (1997-07-01), Rahman
patent: 5653998 (1997-08-01), Hamann
patent: 5683715 (1997-11-01), Boni
patent: 5733888 (1998-03-01), Carver
patent: 5821263 (1998-10-01), Scola et al.
patent: 5869680 (1999-02-01), Mas et al.
patent: 6034072 (2000-03-01), Bruno et al.
patent: 6090955 (2000-07-01), Reszka et al.
patent: 6120798 (2000-09-01), Allen et al.
patent: 6140359 (2000-10-01), Carver et al.
patent: 6306894 (2001-10-01), Carver et al.
patent: 7112338 (2006-09-01), McDonald et al.
patent: 2002/0034537 (2002-03-01), Michaelis et al.
patent: 2002/0090392 (2002-07-01), Campbell et al.
patent: 2003/0187062 (2003-10-01), Zenoni et al.
patent: 2011/0159052 (2011-06-01), Deluca et al.
patent: 1 059 092 (2005-07-01), None
patent: 6-211645 (1993-01-01), None
patent: 99/18113 (1997-10-01), None
patent: 98/22451 (1997-11-01), None
patent: 98/28288 (1997-12-01), None
patent: 99/09021 (1998-08-01), None
patent: 98/40052 (1998-09-01), None
patent: 99/14209 (1998-09-01), None
patent: 98/51278 (1998-11-01), None
patent: 98/58630 (1998-12-01), None
patent: 99/65465 (1999-12-01), None
patent: 00/61543 (2000-10-01), None
patent: 01/05374 (2001-01-01), None
patent: 01/10412 (2001-02-01), None
patent: 01/17508 (2001-03-01), None
patent: 01/25223 (2001-04-01), None
patent: 01/56548 (2001-08-01), None
patent: 01/82899 (2001-11-01), None
patent: 01/93836 (2001-12-01), None
Campbell et al (J Pharm Sci. Aug. 8, 2001; 90(8):1091-1105).
Straubinger et al. (Methods in Enzymology: Taxane-Containing Liposomes. 2005; 391: 97-117).
Regueiro-Ren, et al., SAR and pH Stability of Cyano-Substituted Epothilones, Org. Lett., 2002, 4:3815-3818.
Lee, et al., BMS-247550: A novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy, Clin. Cancer Res., 2001, 7:1429-1437.
Grit, et al., Chemical stability of liposomes: implications for their physical stability, Chemistry and Physics of Lipids, 1993, 64:3-18.
Nicolaou, et al., Recent developments in the chemistry, biology and medicine of the epothilones, Chem. Comm., 2001, 1523-1535.
Altmann, et al., Epothilones and related structures, Biochim. Et Biophys. Acta, 2000, 1470:M79-M91.
Seftow, et al., Derivatization of the C12-C13 functional groups of epothilones A, B and C, Bioorg. & Medicinal Chem. Lett., 1998, 8:3031-3036.
Zuidam, et al., Chemical Hydrolysis of Phospholipids, Journal of Pharmaceutical Sciences, 1995, 84:1113-1119.
Stachel, et al., On the total synthesis and preliminary biological evaluations of 15(R) and 15(S) Aza-dEpoB, Org. Lett., 2000, 2:1637-1639.
Sharma, et al., Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing Liposomes, Pharmaceutical Research, 1994, 11(6):889-896.
Sharma, et al., Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model, Cancer Res, 1993, 53:5877-81.
Sharma, et al., Activity of Paclitaxel Liposome Formulations Against Human Ovarian Tumor Xenografts, Int. J. Cancer, 1997, 71:103-107.
Chou, et al., The synthesis, discovery and development of a highly promising class of microtubule stabilization agents, PNAS, 2001, 98:8113-8118.
Thurston, et al., Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice, J Clin. Invest, 1998, 101(7):1401-13.
Vernooij, et al., Chemical hydrolysis of DOTAP and DOPE in a liposomal environment, Journal of Controlled Release, 2002, 79(1-3):299-303.
Crosasso, et al., Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes, Journal of Controlled Release, 2000, 63:19-30.
Dordunoo, et al., Solubility and Stability of Taxol: effects of buffers and cyclodextrins, International Journal of Pharmaceutics, 1996, 133: 191-201.
Banerjee, J Biomater Appl. 2001, 16(1): 3-21.
Campbell, et al., Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes, J Pharm Sci, 2001, 90(8): 1091-1105.
Ceruti, et al., Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel, Journal of Controlled Release, 2000, 63(1-2): 141-153.
Encyclopedia of Surface and Colloid Science, vol. 1: A-Dif, edited by A. T. Hubbard (2002).

Affiliated with

Also associated with

Rating

Method of producing a cationic liposomal preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of producing a cationic liposomal preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing a cationic liposomal preparation... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4262928